Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin

Sidney Kimmel Cancer Center at Thomas Jefferson University

Status: Terminated

Conditions: Nausea; Metastatic Melanoma

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00716560

2004-101 (Other Identifier)

05C.202

JT 1069 (Other Identifier)

0402005015 (Other Grant/Funding Number)

Details and patient eligibility

About

The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.

Full description

Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth regimen.

Enrollment: 8 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed diagnosis metastatic melanoma
• 18 years and older
• undergoing chemotherapy with Dartmouth regimen
• medically stable to receive chemotherapy per physical and clinical laboratory tests

Exclusion criteria

• No medical conditions that interfere with assessment of nausea and vomiting during chemotherapy
• No cognitive disorder that impairs symptom assessment
• No other investigational agent
• Inability to swallow medications for nausea and vomiting
• No gastric outlet obstruction

Trial design

8 participants in 1 patient group

A

Description:

Metastatic melanoma treatment with Dartmouth regimen